PDUFA Date Orphan Drug Company Status N/A Tepotinib Merck APPROVED 2.3.2021 2.11.2021 Evinacumab Regeneron APPROVED 2.11.2021 2.15.2021 Umbralisib TG Therapeutics APPROVED 2.5.2021
確定! 回上一頁